Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting.

Antonio Craxi, Anna Licata, Calogero Camma', Vito Di Marco, Massimo Colombo, Massimo Levrero, Piero Andreone, Antonio Ascione, Florio Ghinelli, Mario Rizzetto, Maurizia Rossana Brunetto, Alfredo Alberti, Giovanni Battista Gaeta, Luca Saverio Belli, Vincenzo Guadagnino, Ferruccio Bonino, Giampiero Carosi, Antonio Gasbarrini, Nicola Abrescia, Giovanni Di PerriMarcello Caremani, Tommaso Stroffolini, Giovanna Fattovich, Antonio Grieco, Carlo Ferrari, Nicola Caporaso, Giovanni Raimondo, Eleonora De Martin, Teresa Santantanio, Anna Licata, Silvia Ambu, Gianluca Svegliati Baroni, Grazia Niro, Amerigo Paffetti, Anna Orani, Teresa Santantonio, Claudio Puoti, Antonio Craxì, Maria Grazia Rumi, Adriano Lazzarin, Mario Angelico, Paola Nasta, Patrizia Farci, Renato Maserati, Enzo Petrelli, Massimo Galli, Giuseppe Licata, Ivana Maida, Alessandro Rossi, Silvia Ambu, Enzo Ubaldi, Vincenzo Portelli, Teresa Pollicino, Nicoletta Marino, Marcello Tavio, Marcello Caremani, Nicola Coppola, Mario Toti, Bruno Cacopardo, Fabio Piscaglia, Stefano Fagiuoli, Francesca Donato, Massimo Puoti, Umberto Cillo, Calogero Cammà, Evangelista Sagnelli, Gaetano Filice, Florio Ghinelli, Angelo Andriulli, Francesco Mazzotta, Daniele Prati, Patrizia Pontisso, Felice Piccinino, Patrizia Burra, Eligio Pizzigallo, Giovanna Fattovich, Vito Di Marco, Antonina Smedile, Roberto Cauda, Mario Mondelli, Paolo Grossi, Gloria Taliani, Gabriele Missale, Alessandra Mangia, Antonio Picciotto, Giorgio Antonucci, Giovanni Squadrito, Marcello Persico, Raffaele Bruno, Savino Bruno, Giuseppe Cariti, Giuseppe Pastore, Andrea De Luca

Risultato della ricerca: Article

54 Citazioni (Scopus)

Abstract

It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies
Lingua originaleEnglish
pagine (da-a)81-91
Numero di pagine11
RivistaDigestive and Liver Disease
Volume42
Stato di pubblicazionePublished - 2010

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Gastroenterology

Cita questo

Craxi, A., Licata, A., Camma', C., Di Marco, V., Colombo, M., Levrero, M., Andreone, P., Ascione, A., Ghinelli, F., Rizzetto, M., Brunetto, M. R., Alberti, A., Gaeta, G. B., Belli, L. S., Guadagnino, V., Bonino, F., Carosi, G., Gasbarrini, A., Abrescia, N., ... De Luca, A. (2010). Practice guidelines for the treatment of hepatitis C: recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting. Digestive and Liver Disease, 42, 81-91.